HMD - HeraMED Limited

HeraMED Limited (HMD) is a technology startup based in Israel and is developing a lineup of innovative connected pregnancy monitoring solutions for home use. Harnessing state-of-the-art technology with superior UX/UI, HeraMED creates solutions that are "medically accurate, scientifically optimized, safe and affordable".

The company’s HeraBEAT fetal heartbeat monitor provides medical-grade heart rate monitoring at home through a smartphone connection, the company says.

Israel’s largest and most advanced hospital, Sheba Medical Centre, this month began a pilot program to test both the device and the HeraCARE platform, and the company also has a research collaboration with the Mayo Clinic in the United States.

Microcap investor Altor Capital just became a “substantial holder” of this $19 million Israeli medtech.

“It’s been through the really capital intensive period of its lifecycle, it’s done the research and development, it’s gone through all the regulatory hurdles, and they’ve validated the technology through some key integrations and key relationships that they have on a global level,” portfolio manager David McNamee said.
“So what we see with that business is that a lot of the risks have been diminished in the terms of the capital expenditure, and it’s just purely about them being able to execute on the commercial outcomes and expand their business now,” McNamee continued.

Click to expand...

“So that’s why we’re really excited about that business, because we can see it really scaling very very significantly on a global level. And you’re getting buy-in from the key healthcare practitioners and hospital groups to actually enable that.”

Click to expand...

HeraMED’s heartbeat monitoring device is “statistically the same” as $10,000 foetal monitoring devices currently on the market, but costs about one-tenth the price, McNamee said.

“We’ve got a pretty high conviction on that business… we see that as a severely mispriced asset, given the hard work and what’s been achieved to date on a typical research and development level"

Click to expand...

Sorry to hear about how Israe's ls going, HMD shot through the roof', been watching for a bit now, well pass resistance'...Going strong today, wonder what tomorrow's gunner bring?...

Stockybailz said:

Sorry to hear about how Israel's going, HMD shot through the roof', been watching for a bit now, well pass resistance'...Going strong today, wonder what tomorrow's gunner bring?...

Click to expand...

But HMD takes another shot out of the dark;

HeraMED is a technology startup developing a lineup of innovative connected pregnancy monitoring solutions for home use. Harnessing state-of-the-art technology with superior UX/UI, we are creating solutions that are medically accurate, scientifically optimized, safe and affordable.

https://hera-med.com/

Chart update.

frugal.rock said:

Chart update.

Click to expand...

is there a pulse?


.
entitlement issue of 1 new Share for every 5 existing Shares held by Eligible Shareholders at an issue price of $0.02 per New Share to raise up to approx. $1.28 million (before costs) - dispatched on 29 January 2024.

MC $6M

Dona Ferentes said:

is there a pulse?

Click to expand...

Nearby addressable market diminishing daily.